Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (FRA:GU5)

Market Cap	4.41B -10.7%
Revenue (ttm)	9.87B +5.3%
Net Income	370.38M +9.1%
EPS	0.23 +9.2%
Shares Out	n/a
PE Ratio	11.91
Forward PE	12.07
Dividend	0.06 (3.27%)
Ex-Dividend Date	Jun 12, 2026

Volume	n/a
Open	1.750
Previous Close	1.740
Day's Range	1.750 - 1.750
52-Week Range	1.550 - 2.300
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 22, 2026

About FRA:GU5

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the pharmaceutical and healthcare industry in the People’s Republic of China and internationally. The company operates through Modern Chinese Medicine Business, Chemical Pharmaceutical Technology Business, Natural Beverage Business, Pharmaceutical Commercial Business, and Other segments. It is involved in the research, development, manufacturing, and sale of chemical drugs, chemical raw materials, and chemical raw material intermediates; and research, development, productio...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1997
• Employees: 27,057
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: GU5

Financial Performance

In 2025, FRA:GU5's revenue was 77.66 billion, an increase of 3.55% compared to the previous year's 74.99 billion. Earnings were 2.98 billion, an increase of 5.21%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jul 21, 2026

Data Sources Report a data error